Tens of thousands of patients awaiting life-changing joint replacements face imminent surgery cancellations due to a critical global shortage of bone cement. The NHS's primary supplier, Heraeus, revealed a 'critical machine failure' during a system upgrade, leading to a severe scarcity with only one week's supply remaining. This crisis affects approximately 850,000 patients in England currently on waiting lists for joint replacement surgery.

Hospitals have been instructed to cancel non-emergency appointments for the next two months and prioritize emergency trauma cases. This means roughly 1,000 emergency trauma operations per week requiring cement, such as those for elderly patients with hip fractures, will be pushed to the forefront. This prioritization comes despite 22,000 patients having already endured waits longer than a year for their procedures. Experts warn that the two-month projection is a best-case scenario, and the disruption could mirror the extended waiting times experienced during the Covid-19 pandemic, with no clear resolution in sight.

The impact of the shortage will vary across the UK, as highlighted by an interactive map revealing hospitals with existing long waits. Mid and South Essex NHS Foundation Trust currently has the largest number of patients awaiting knee and hip operations, exceeding 19,100. Conversely, Kettering General Hospital NHS Foundation Trust, which manages multiple sites including Isebrook Hospital and Market Harborough District Hospital, reports a shorter waiting list with just over 1,860 patients.

Bone cement is a crucial ingredient, used to securely lock joint replacements in place, facilitating quicker patient recovery. It is integral to the majority of the 250,000 joint replacement procedures performed annually. Data from the UK's National Joint Registers (NJR) indicates that around 200,000 first-time knee and hip procedures in 2024 alone utilized cement. Specifically, it is estimated to be used in over 80 percent of knee replacements and almost 60 percent of hip replacements, equating to approximately 15,000 operations each month.

The supplier, Heraeus, has confirmed that the 'supply shortage for at least the next two months' means close to a million patients face further delays. This situation will inevitably lead to increased pressure on the independent sector, which has been advised to suspend cement supply for non-clinically urgent cases. The financial repercussions are also significant; research from the University of Bristol estimates each short-notice cancelled knee replacement costs the NHS between £6,500 and £11,000 in lost tariffs, potentially accumulating tens of millions annually.

Healthcare leaders, including the British Orthopaedic Directors Society and the British Orthopaedic Association (BOA), have acknowledged the 'seriousness of the shortage' and the likely need to restrict activity to trauma and urgent cases. Fergal Monsell, president of the BOA, stated that while the association is working to mitigate patient impact, the situation is 'beyond the control of trauma and orthopaedic surgeons and NHS organisations.' He also suggested that NHS trusts utilize freed-up theatre time for orthopaedic procedures not requiring cement.

Dr. Alex Dickinson, Professor of Prosthetics Engineering at the University of Southampton, underscored the difficulty of finding alternative solutions, noting that